Pro Medicus press release ( PMCUF ): 1H GAAP EPS of 163.60¢. Revenue of $128.94M (+27.9% Y/Y). More on Pro Medicus Limited Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript Seeking Alpha’s Quant Rating on Pro Medicus Limited Historical earnings data for Pro Medicus Limited Dividend scorecard for Pro Medicus Limited Financial information for Pro Medicus Limited
Pro Medicus press release ( PMCUF ): 1H GAAP EPS of 163.60¢. Revenue of $128.94M (+27.9% Y/Y). More on Pro Medicus Limited Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript Seeking Alpha’s Quant Rating on Pro Medicus Limited Historical earnings data for Pro Medicus Limited Dividend scorecard for Pro Medicus Limited Financial information for Pro Medicus Limited
tofumax/iStock Editorial via Getty Images McDonald’s ( MCD ) is emerging as a winner in the fast-food sector by leaning into value-oriented pricing and strategic promotions, according to investment expert Victoria Greene of G Squared Private Wealth. In an interview with CNBC, Greene explained that McDonald’s deep understanding of its customer base is driving same-store sales growth while competito...
tofumax/iStock Editorial via Getty Images McDonald’s ( MCD ) is emerging as a winner in the fast-food sector by leaning into value-oriented pricing and strategic promotions, according to investment expert Victoria Greene of G Squared Private Wealth. In an interview with CNBC, Greene explained that McDonald’s deep understanding of its customer base is driving same-store sales growth while competitors like Chipotle ( CMG ) struggle to connect with value-conscious diners. “What Chipotle is losing, McDonald’s gaining,” Greene said during the interview, highlighting the contrast between the two chains’ approaches to pricing. She noted that while Chipotle has signaled it won’t offer dollar menu items, McDonald’s continues to attract customers with its $5 and $8 value meals and promotional offerings like the Snack Wrap. Greene praised the company’s operational excellence and franchisee support, describing McDonald’s leadership as particularly effective. “They’re great at promotion. They’re wonderful at supporting their franchisees. They’re building out. They’re growing same-store sales,” she explained. The analyst also pointed to the company’s ambitious expansion plans to 50,000 locations as evidence of its growth trajectory. The investment strategist emphasized McDonald’s sophisticated approach to customer engagement through its app loyalty program. “They just know their consumers so well, so they’re able to price things well. They know when to hold them and know when to increase,” Greene said. She described the company’s business structure, including its ownership of real estate, as “brilliant.” Looking at the company’s product mix, Greene noted that McDonald’s has achieved a roughly fifty-fifty balance between chicken and beef offerings. While she indicated her firm is watching margins carefully, she expects management to strike an upbeat tone given the strength of their consumer insights and operational execution. Greene recommended McDonald’s as a solid blue-chip core...
Flex LNG Ltd (Symbol: FLNG) has been named as a Top 10 dividend paying energy stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among energy companies, FLNG shares displayed both attractive valuation metrics and str
Flex LNG Ltd (Symbol: FLNG) has been named as a Top 10 dividend paying energy stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among energy companies, FLNG shares displayed both attractive valuation metrics and str
mohd izzuan Shares of Viking Therapeutics ( VKTX ) continued to rise in the premarket on Thursday after the company provided encouraging updates on its experimental obesity therapy, VK2735, with its Q4 2025 results. However, the California-based biotech’s bottom line trailed estimates as its non-GAAP EPS more than quadrupled to $1.38, missing the consensus by $0.48, driven by R&D expenses, which r...
mohd izzuan Shares of Viking Therapeutics ( VKTX ) continued to rise in the premarket on Thursday after the company provided encouraging updates on its experimental obesity therapy, VK2735, with its Q4 2025 results. However, the California-based biotech’s bottom line trailed estimates as its non-GAAP EPS more than quadrupled to $1.38, missing the consensus by $0.48, driven by R&D expenses, which rose to $153.5M from $31.5M in the prior year period amid expenses related to clinical trials. "The past year was an exceptional year for Viking, marked by rapid progress across our obesity portfolio," said CEO Brian Lian with the earnings release issued on Wednesday after the close. Viking’s ( VKTX ) notable pipeline updates include the plans to begin a late-stage trial for an oral version of its GLP-1 obesity candidate VK2735 in Q3 2026. Additionally, the company disclosed that a Phase 1 study, designed to evaluate various oral and injectable maintenance dosing regimens of VK2735, is fully enrolled, with its data expected in Q3 2026. Meanwhile, Viking ( VKTX ) intends to submit an Investigational New Drug application with the FDA in Q1 2026, seeking regulatory clearance for a clinical trial targeting its lead amylin agonist for obesity. As for liquidity, the company maintained a strong cash position, recording $706M of cash, cash equivalents, and short-term investments as of Dec. 31 compared to $903M a year ago. “Throughout these activities, we have continued to exercise fiscal discipline and maintain a strong balance sheet, which will allow us to meet key milestones in the quarters ahead,” Lian added. More on Viking Therapeutics Viking Therapeutics, Inc. (VKTX) Q4 2025 Earnings Call Transcript The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short Viking Therapeutics, Inc. (VKTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Viking Therapeutics outlines dual Phase III obesity programs while advancing oral VK2735 and maintenan...
American States Water Co (Symbol: AWR) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.8% yield, as well as a superb track record of at least two decades of dividend growth, accor
American States Water Co (Symbol: AWR) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.8% yield, as well as a superb track record of at least two decades of dividend growth, accor
National Fuel Gas Co. (Symbol: NFG) has been named as a Top 10 dividend paying utility stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among utilities, NFG shares displayed both attractive valuation metrics and st
National Fuel Gas Co. (Symbol: NFG) has been named as a Top 10 dividend paying utility stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among utilities, NFG shares displayed both attractive valuation metrics and st
Chile’s female players are newly protected under labour law and are hoping their official status can help the game thrive in South America The Chilean players’ association officially became a union in December, and its president, Javiera Moreno, believes there needs to be women’s representation in players’ unions around the world. “We want this movement to become massive,” says the former Universi...
Chile’s female players are newly protected under labour law and are hoping their official status can help the game thrive in South America The Chilean players’ association officially became a union in December, and its president, Javiera Moreno, believes there needs to be women’s representation in players’ unions around the world. “We want this movement to become massive,” says the former Universidad Católica captain. “Our goal is to spread this to other countries. I don’t know if in other places the path will be to have a specific union for women. This was needed here, but I think there needs to be at least representation of women’s players within every country’s footballers’ union.” Continue reading...
Tamboran Resources press release ( TBN ): Q2 GAAP EPS of -$0.33. More on Tamboran Resources Seeking Alpha’s Quant Rating on Tamboran Resources Historical earnings data for Tamboran Resources Financial information for Tamboran Resources
Tamboran Resources press release ( TBN ): Q2 GAAP EPS of -$0.33. More on Tamboran Resources Seeking Alpha’s Quant Rating on Tamboran Resources Historical earnings data for Tamboran Resources Financial information for Tamboran Resources
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, explains why we are nowhere close to an end of the bull market. (Source: Bloomberg)
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, explains why we are nowhere close to an end of the bull market. (Source: Bloomberg)
JUNG LIN SU/iStock via Getty Images Outlook for Taiwan in 2026 Taiwan's stock market had another stellar year of performance in 2025, and the outlook in 2026 is also favorable due to recent growth trends in the economy. Data by YCharts The Taiwan Fund ( TWN ) has outperformed emerging markets by around 140 percentage points in the past three years. This momentum will likely continue during the fir...
JUNG LIN SU/iStock via Getty Images Outlook for Taiwan in 2026 Taiwan's stock market had another stellar year of performance in 2025, and the outlook in 2026 is also favorable due to recent growth trends in the economy. Data by YCharts The Taiwan Fund ( TWN ) has outperformed emerging markets by around 140 percentage points in the past three years. This momentum will likely continue during the first half of 2026, as major institutions have recently upgraded Taiwan's economic outlook. However, performance will not likely be as strong as it was in 2023-2025. The Taiwan Fund has rallied significantly since my last coverage of this fund in July 2024 . I am downgrading my rating from a buy to hold now, and think it may be a good idea to sell into the strength following H1 2026. Taiwan already trades at a massive premium to emerging markets, which may limit market returns this year. Moreover, EMs had a solid run and may be due for a pullback in 2026. TWN looks like a solid hold at the moment, and it looks ideal to take some profits later in 2026 if the market continues to rally this year. The macro data should support the market in 2026, but returns will likely be limited in future years. Taiwan Macro Developments are Favorable Equities in Taiwan will likely rally even more during the first half of this year on the back of extremely favorable macro news. Taiwan is poised to be a clear victor within emerging markets this year. Bank of America recently raised its growth projections for Taiwan from 4.5% to 8% , citing massive AI demand this year. This upgrade was largely driven by Taiwan's superior performance in Q4 2025 , which was a multi-decade high growth rate. ING Taiwan's export growth soared by 69.9% YoY last month , up from 43.4% in December. Taiwan's export growth has risen from the previous slump and has a solid long-term trajectory ahead of it. Macromicro Despite trade war rhetoric, the United States was a massive source of growth for Taiwan (over 100% export grow...